Skip to main content
Menu
US

LANCE Eu-W1024 Anti-Human c-Myc Antibody, 10µg

Europium-labeled anti-c-myc antibody, for capturing c-myc-tagged proteins in LANCE® TR-FRET assays.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Part number: AD0206
Unit Size: 10 µg
List price: USD 423.80
Your price:
USD 423.80
USD 423.80 /each
Part number: AD0114
Unit Size: 50 µg
List price: USD 1,673.00
Your price:
USD 0.00
USD 1,673.00 /each
Part number: AD0115
Unit Size: 1 mg
List price: USD 20,460.00
Your price:
USD 0.00
USD 20,460.00 /each

Overview

LANCE® Eu-labeled anti-c-myc antibodies are purified mouse IgG1 monoclonal antibodies, which recognize the epitope sequence (EQKLISEEDL) derived from the human c-myc protein. These monoclonal antibodies against the c-myc epitope do not cross react with other cellular proteins.

LANCE® (Lanthanide chelate excite) and LANCE® Ultra are our TR-FRET (time-resolved fluorescence resonance energy transfer), homogeneous (no wash) technologies. One molecule of interest is labeled with a donor fluorophore (a LANCE Europium chelate) and the second molecule is labeled with an acceptor fluorophore [ULight™ dye, allophycocyanin (APC), etc.]. Upon excitation at 320 or 340 nm, energy can be transferred from the donor Europium chelate to the acceptor fluorophore if sufficiently close for FRET (~10 nm). This results in the emission of light at 665 nm (for ULight dye and APC).

Specifications

Antibody Conjugates
Anti-c-Myc
Application
Protein-protein interactions
Automation Compatible
Yes
Brand
LANCE
Detection Method
Time-Resolved Fluorescence (TRF)
TR-FRET
Experimental Type
In vitro
Fluorophore
Eu-W1024
Format
Microplates
Shipping Conditions
Shipped in Dry Ice
Unit Size
10 µg

Resources

1-1 of 1 Resources
Application Note Icon
Application Note
Developing a LANCE TR-FRET assay for screening PD-1 and PD-L1 binding inhibitors.

Here, we demonstrate the utility and benefits of using LANCE Ultra TR-FRET assay technology for identifying and characterizing PD...

Scroll Icon